CD34+ HSPC expansion and culture: methods, conditions, and optimization

Reliable expansion of CD34⁺ hematopoietic stem and progenitor cells (HSPCs) in in vitro culture is essential when you’re developing cell and gene therapy applications.

CD34⁺ HSPCs generate all mature blood and immune cells, making them an important tool for cell and gene therapy. Hematopoietic progenitor cells (HPCs), a key HSPC subset, drive downstream differentiation. Expanding these cells outside the body can be challenging. Donor variability, undefined serum components, and differentiation pressure during culture can make it challenging to reliably expand HSPCs in vitro.

You can isolate CD34⁺ HSPCs from mobilized peripheral blood, bone marrow, and cord blood. Each source has a different frequency and expansion potential of CD34⁺ cells, making baseline cell characterization essential.^1–3 

A typical isolation workflow includes:

1. Collection from your source of choice (bone marrow, cord blood, or mobilized peripheral blood)
2. Pre-processing via density gradient separation to remove red blood cells and debris
3. Immunomagnetic CD34⁺ selection to enrich for HSPCs by positive selection for CD34⁺ surface expression^4,5

Standardizing these steps early reduces variability in downstream expansion.

Native cell sources rarely yield enough CD34⁺ HSPCs for therapeutic or research use. In vitro cell expansion helps you overcome this bottleneck. Expansion helps you increase the number of CD34+ HSPCs without driving differentiation.

To expand CD34⁺ HSPCs, seed cells at a defined density and culture them with cytokines that promote proliferation.⁶ TPO, SCF, FLT 3 ligand, and IL 3 are commonly used to support the expansion of HPCs.  CD34+ HSPC expansion typically requires frequent medium changes and fed-batch culture.7 These approaches help reduce the accumulation of inhibitory factors secreted by differentiating cells.

Looking for a defined medium optimized for HPC expansion?

Figure 1: CD34⁺ HPC expansion in culture. A) The figure shows flow cytometry analysis of our CD34+ progenitor cells on day 0 of culture. B) Representative data of the expansion of human cord blood CD34+ cells after 13 days of culture. Cells were expanded using the HPC Expansion Medium XF or competitor medium.

Each variable in your HSPC expansion protocol can influence the quality of your CD34+ cells. The table below summarizes the variables that determine expansion quality, why each one matters, and what to measure or record as evidence.

Table 1: Variables influencing HSPC expansion quality.

These variables shape the functional composition of the expanded population, including the proportion and performance of HPCs required for downstream applications. Control them from the start to avoid compatibility issues, especially if you change medium format mid-study.

There are three stages to moving CD34⁺ HSPC expansion from a research setting toward a more regulated environment.

Establish baseline expansion performance using your cell source of choice.

• Define baseline conditions: Document donor variability, seeding density, and cytokine concentration.
• Track performance metrics: Measure expansion fold and %CD34 retention.
• Capture functional output: Run CFU assays and phenotyping to capture functional data at baseline.

Use defined media solutions to improve consistency and reduce variability.

• Serum-free, xeno-free formulations, such as our Hematopoietic Progenitor Cell Expansion Medium XF, support expansion of hemtapoietic progenitor cells under defined conditions.
• Fine-tune cytokine supplementation to balance proliferation and phenotype retention.
• Revisit seeding density and feeding intervals based on your benchmarking data.

Align your workflow with regulatory expecations before scale-up.

• Choose fit-for-purpose reagents: Our PromoExQ HPC Epxansion Medium XF is formulated to support workflows moving toward regulated environments, with Excipient GMP-greade* status and full documentation support.
• Build your process characterization package: Compile donor variability data, lot strategy, and comparability readouts.
• Plan for traceability: Ensure every reagent and process step is documented.

*“GMP-grade” is a branding term used by PromoCell to denote reagents that are manufactured at the PromoCell manufacturing facility in Heidelberg, Germany, under strictly controlled processes to meet stringent product specifications and customer requirements. Reagents manufactured at PromoCell are produced according to EXCiPACT™ GMP standards, a quality management system that builds on our ISO 9001:2015 certification. Risk assessment procedures are carried out at the customer site.

References